Sun Pharmaceutical Industries Ltd.
-61.55 (-3.68%) Sun Pharma’s unit recalls 5,322 bottles of Ketorolac eye drop in US
Date: 09-03-2015Sun Pharmaceutical Industries’ US-based unit Sun Pharma Global Fze has voluntarily recalled 5,322 bottles of Ketorolac Tromethamine ophthalmic solution in the US market for failing to meet specifications.
The ophthalmic solution falls under non-steroidal anti-inflammatory drug (NSAID) category and is indicated for relief from pain and inflammation in the eyes. The drug was manufactured by Mumbai-based Sun Pharmaceutical Industries at its Halol facility in Gujarat and distributed by Caraco Pharmaceutical Laboratories in the US market. The recall was initiated by the company on January 21 this year.
Sun Pharmaceutical Industries is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.